BellRing Brands Inc. (NYSE: BRBR) is a prominent player in the nutrition industry, known for its protein-focused products. The company operates in a competitive market, with rivals like Glanbia and Abbott Laboratories. On August 7, 2025, Barclays adjusted its rating for BellRing Brands to "Overweight," maintaining its previous grade. Despite this, the stock price was $38.95 at the time of the update.
Barclays also revised its price target for BellRing Brands, lowering it from $75 to $50. This adjustment comes amid an ongoing investigation by Bragar Eagel & Squire, P.C. into potential violations of federal securities laws by BellRing Brands. The investigation, led by Litigation Partner Brandon Walker, is urging investors who have incurred losses to explore their legal options.
The investigation follows BellRing Brands' second-quarter 2025 earnings call on May 6, where it was revealed that some customers were choosing to "optimize" their inventory. This decision by customers could have significant implications for the company's financial performance, potentially affecting its stock price and market perception.
Currently, BellRing Brands' stock is priced at $38.95, reflecting a 7.66% increase or $2.77. The stock has fluctuated between a low of $36.33 and a high of $39.25 today. Over the past year, BRBR has seen a high of $80.67 and a low of $34.02, indicating significant volatility in its stock performance.
BellRing Brands has a market capitalization of approximately $4.95 billion, with a trading volume of 11.44 million shares on the NYSE. These figures highlight the company's substantial presence in the market, despite the challenges it faces with the ongoing investigation and customer inventory optimization.
Symbol | Price | %chg |
---|---|---|
PANI.JK | 15800 | 0 |
ICBP.JK | 9350 | 0 |
INDF.JK | 8150 | 0 |
MYOR.JK | 2210 | 0 |
BellRing Brands, Inc. (NYSE: BRBR) is currently under investigation by Holzer & Holzer, LLC, a law firm specializing in securities litigation. This inquiry aims to assess the company's adherence to federal securities laws following its third-quarter 2025 financial report, which highlighted a decrease in net earnings from the previous year. Additionally, BellRing Brands has revised its fiscal year 2025 outlook, adjusting its net sales and Adjusted EBITDA projections downward. This news has negatively impacted the company's stock price, prompting Holzer & Holzer to call on investors who have incurred losses to explore their legal options. The firm is known for securing recoveries for shareholders affected by such issues.
Despite these financial setbacks, there are signs of insider confidence in the company's future. On August 6, 2025, STEIN ELLIOT JR, a director at BRBR, invested in 2,663 shares at a price of $37.49 each, bringing his total holdings to 5,198 shares. This action suggests that some insiders believe in the company's potential for recovery and growth despite recent challenges.
Barclays has also provided its perspective on BellRing Brands, maintaining an "Overweight" rating while adjusting its price target from $75 to $50. As of this update, the stock was trading at $38.95. Currently, BRBR's stock is valued at $40.16, marking a 3.09% increase. The stock has experienced fluctuations between $38.87 and $41.19 in today's trading session.
BellRing Brands boasts a market capitalization of approximately $5.1 billion, with a trading volume of 4,444,987 shares on the NYSE. Over the past year, the stock has oscillated between a high of $80.67 and a low of $34.02, indicating significant volatility and investor interest amid the company's ongoing developments.
BellRing Brands, Inc. (NYSE:BRBR) is a key player in the convenient nutrition sector, known for its popular brands like Premier Protein and Dymatize. These brands offer ready-to-drink protein shakes and powders, catering to the growing demand for health-focused nutrition products. Despite its strong market presence, BRBR is currently under investigation for potential violations of federal securities laws.
On August 7, 2025, Andrew Lazar from Barclays set a price target of $50 for BRBR, suggesting a potential increase of approximately 28.37% from its current price of $38.95. This target was adjusted down from a previous target of $75, as reported by TheFly. The stock has shown some volatility, with a recent fluctuation between $36.33 and $39.25, and a 7.66% increase or $2.77 rise in its price.
The investigation by Bleichmar Fonti & Auld LLP was triggered by a drop in BellRing's stock price. Despite the company's claims of strong demand and growth, discrepancies in these statements have led to scrutiny. The stock has seen a high of $80.67 and a low of $34.02 over the past year, reflecting significant price movements.
BellRing's market capitalization is approximately $4.95 billion, indicating its substantial size in the market. The trading volume for BRBR today is 11.44 million shares on the NYSE, showing active investor interest. Investors should stay informed about the ongoing investigation and its potential impact on the company's future performance.
BellRing Brands, Inc. (NYSE:BRBR) is set to release its quarterly earnings on November 18, 2024. The company, known for its nutritional products, is expected to report earnings per share (EPS) of $0.50 and revenue of approximately $535.62 million. Analysts and investors are keenly observing these figures, as they will provide insight into the company's financial health and market performance.
The anticipation surrounding BellRing's earnings report is heightened by expectations of a year-over-year increase in earnings, driven by higher revenues for the quarter ending September 2024. Investors are particularly interested in whether BellRing will exceed these expectations, as a positive earnings surprise could lead to a rise in the stock price. Conversely, failing to meet these expectations might result in a decline.
BellRing Brands has a history of surpassing earnings expectations, which adds to the optimism. The company currently holds a price-to-earnings (P/E) ratio of 42.45, indicating how much investors are willing to pay per dollar of earnings. Its price-to-sales ratio is about 4.87, reflecting the value placed on each dollar of the company's sales. These metrics suggest a strong market valuation.
The enterprise value to sales ratio of 5.27 and the enterprise value to operating cash flow ratio of 41.26 further highlight BellRing's valuation relative to its sales and cash flow from operations. The earnings yield of 2.36% represents the percentage of each dollar invested that was earned by the company, providing insight into its profitability.
BellRing's financial leverage is indicated by a debt-to-equity ratio of -3.42, while its current ratio of 2.67 suggests a solid ability to cover short-term liabilities with short-term assets. These financial metrics will be crucial in assessing the company's performance and future prospects during the upcoming earnings call.
BellRing Brands, Inc. (NYSE:BRBR) is set to release its quarterly earnings on November 18, 2024. The company, known for its nutritional products, is expected to report earnings per share (EPS) of $0.50 and revenue of approximately $535.62 million. Analysts and investors are keenly observing these figures, as they will provide insight into the company's financial health and market performance.
The anticipation surrounding BellRing's earnings report is heightened by expectations of a year-over-year increase in earnings, driven by higher revenues for the quarter ending September 2024. Investors are particularly interested in whether BellRing will exceed these expectations, as a positive earnings surprise could lead to a rise in the stock price. Conversely, failing to meet these expectations might result in a decline.
BellRing Brands has a history of surpassing earnings expectations, which adds to the optimism. The company currently holds a price-to-earnings (P/E) ratio of 42.45, indicating how much investors are willing to pay per dollar of earnings. Its price-to-sales ratio is about 4.87, reflecting the value placed on each dollar of the company's sales. These metrics suggest a strong market valuation.
The enterprise value to sales ratio of 5.27 and the enterprise value to operating cash flow ratio of 41.26 further highlight BellRing's valuation relative to its sales and cash flow from operations. The earnings yield of 2.36% represents the percentage of each dollar invested that was earned by the company, providing insight into its profitability.
BellRing's financial leverage is indicated by a debt-to-equity ratio of -3.42, while its current ratio of 2.67 suggests a solid ability to cover short-term liabilities with short-term assets. These financial metrics will be crucial in assessing the company's performance and future prospects during the upcoming earnings call.